SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The effect of pharmacy benefit design on patient-physician communication about costs
10 references·3 citing·41 second hop
The effect of pharmacy benefit design on patient-physician communication about costs (2006)The effect of pharmacy benefit design on …Health Care in the 21st Century (2005)Health Care in the 21st Centu…The Health Effects of Restricting Prescription Medication Use Because of Cost (2004)The Health Effects of Restric…Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Pharmacy Benefits and the Use…The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending (2003)The Effect of Incentive-Based…Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Adverse Events Associated Wit…Who Bears The Burden Of Medicaid Drug Copayment Policies? (1999)Who Bears The Burden Of Medic…Financial Incentives And Drug Spending In Managed Care (1999)Financial Incentives And Drug…The effects of copayments and generic substitution on the use and costs of prescription drugs. (1993)The effects of copayments and…The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization (1990)The Effect of Drug Co-Payment…The differential impact of copayment on drug use in a Medicaid population. (1985)The differential impact of co…Physician–Patient Communication on Cost and Affordability in Asthma Care. Who Wants to Talk about It and Who Is Actually Doing It (2014)Physician–Patient Communicati…Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? (2006)Physicians' perceptions of re…Physicians’ Perceived Knowledge of and Responsibility for Managing Patients’ Out-of-Pocket Costs for Prescription Drugs (2006)Physicians’ Perceived Knowled…Health, economics, and health economics (1982)Financial Incentives for Physicians in HMOs (1987)Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. (2002)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Cost-sharing: effects on spending and outcomes. (2010)The demand for prescription drugs as a function of cost-sharing (1985)Payment Restrictions for Prescription Drugs under Medicaid (1987)Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization (2001)Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Pharmaceutical policies: effects of cap and co-payment on rational drug use (2008)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)The effects of prescription drug cost sharing: a review of the evidence. (2005)The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2010)Unequal treatment: confronting racial and ethnic disparities in health care (2003)Class — The Ignored Determinant of the Nation's Health (2004)Income, Poverty, and Health Insurance Coverage In The United States: 2003 (2004)Health Savings Accounts — The Ownership Society in Health Care (2005)Managed Consumerism In Health Care (2005)The CES-D Scale (1977)Self-Rated Health and Mortality: A Review of Twenty-Seven Community Studies (1997)Analysis of Health Surveys (1999)The Effect of Medicare Part D on Drug and Medical Spending (2009)Hospitalizations and Deaths Among Adults With Cardiovascular Disease Who Underuse Medications Because of Cost (2010)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes (2005)The impact of patient cost-sharing on low-income populations: Evidence from Massachusetts (2013)American Economic Review (2019)Free for All? Lessons from the RAND Health Insurance Experiment (1995)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)The theory and practice of econometrics (1986)The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. (1999)Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? (2006)In search of a corrected prescription drug Elasticity estimate: a meta‐regression approach (2007)The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members (1997)Income‐Related Differences in the Use of Evidence‐Based Therapies in Older Persons with Diabetes Mellitus in For‐Profit Managed Care (2003)Socioeconomic Position and Health among Persons with Diabetes Mellitus: A Conceptual Framework and Review of the Literature (2004)Unintended Consequences of Caps on Medicare Drug Benefits (2006)Patient Cost-Sharing and Hospitalization Offsets in the Elderly (2010)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)
this work references cited by second hop

References

  • 2001Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons873 cited
  • 2004Pharmacy Benefits and the Use of Drugs by the Chronically Ill530 cited
  • 2003The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending334 cited
  • 2004The Health Effects of Restricting Prescription Medication Use Because of Cost317 cited
  • 1990The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization188 cited
  • 1999Who Bears The Burden Of Medicaid Drug Copayment Policies?153 cited
  • 1999Financial Incentives And Drug Spending In Managed Care137 cited
  • 2005Health Care in the 21st Century114 cited
  • 1985The differential impact of copayment on drug use in a Medicaid population.112 cited
  • 1993The effects of copayments and generic substitution on the use and costs of prescription drugs.73 cited

Cited by

  • 2006Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?52 cited
  • 2014Physician–Patient Communication on Cost and Affordability in Asthma Care. Who Wants to Talk about It and Who Is Actually Doing It47 cited
  • 2006Physicians’ Perceived Knowledge of and Responsibility for Managing Patients’ Out-of-Pocket Costs for Prescription Drugs47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work